Literature DB >> 7197686

Microassay of inorganic sulfate in biological fluids by controlled flow anion chromatography.

D E Cole, C R Scriver.   

Abstract

The application of controlled flow anion chromatography to the assay of inorganic sulfate in biological fluids is described. The sulfate anion is separated from other anions by ion-exchange chromatography and quantitated conductimetrically. Coefficient of variance is 3.4%, about half that for the barium precipitation assay. Interference from heparin in plasma samples and unknown sources in tissue extract analysis is avoided. Sulfate levels in plasma are not different from those measured in serum after protein precipitation. Normal levels for sulfate concentration in human plasma, cerebrospinal fluid and hepatic tissue extract are reported.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7197686     DOI： 10.1016/s0378-4347(00)80284-4

Source DB:  PubMed          Journal:  J Chromatogr


  5 in total

1.  Dietary therapy in two patients with a mild form of sulphite oxidase deficiency. Evidence for clinical and biological improvement.

Authors:  G Touati; E Rusthoven; E Depondt; C Dorche; M Duran; B Heron; D Rabier; M Russo; J M Saudubray
Journal:  J Inherit Metab Dis       Date:  2000-02       Impact factor: 4.982

2.  Circadian rhythm of serum sulfate levels in man and acetaminophen pharmacokinetics.

Authors:  D A Hoffman; S M Wallace; R K Verbeeck
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Absence of hepatic molybdenum cofactor: an inborn error of metabolism leading to a combined deficiency of sulphite oxidase and xanthine dehydrogenase.

Authors:  S K Wadman; M Duran; F A Beemer; B P Cats; J L Johnson; K V Rajagopalan; J M Saudubray; H Ogier; C Charpentier; R Berger
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

4.  Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias.

Authors:  J Hästbacka; A Superti-Furga; W R Wilcox; D L Rimoin; D H Cohn; E S Lander
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025

5.  Chemical and biomechanical characterization of hyperhomocysteinemic bone disease in an animal model.

Authors:  Priscilla G Massé; Adele L Boskey; Israel Ziv; Peter Hauschka; Sharon M Donovan; David S Howell; David E C Cole
Journal:  BMC Musculoskelet Disord       Date:  2003-02-20       Impact factor: 2.362
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.